树突细胞生物学演变为临床应用.

Same author

Distinguishing human peripheral blood CD16<sup>+</sup> myeloid cells based on phenotypic characteristics.

Journal of leukocyte biology·2019

Same author

CD300f epitopes are specific targets for acute myeloid leukemia with monocytic differentiation.

Molecular oncology·2019

Same author

CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential.

Frontiers in immunology·2019

Same author

Examination of CD302 as a potential therapeutic target for acute myeloid leukemia.

PloS one·2019

Same author

The cell surface phenotype of human dendritic cells.

Seminars in cell & developmental biology·2018

Same author

Dendritic cells as cancer therapeutics.

Seminars in cell & developmental biology·2018

Same journal

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Lancet (London, England)·2026

Same journal

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Lancet (London, England)·2026

Same journal

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Lancet (London, England)·2026

Same journal

Documenting hospice care.

Lancet (London, England)·2026

Same journal

After the wood chipper.

Lancet (London, England)·2026

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

相关实验视频

树突细胞生物学演变为临床应用.

相关概念视频

Distinguishing human peripheral blood CD16<sup>+</sup> myeloid cells based on phenotypic characteristics.

CD300f epitopes are specific targets for acute myeloid leukemia with monocytic differentiation.

CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential.

Examination of CD302 as a potential therapeutic target for acute myeloid leukemia.

The cell surface phenotype of human dendritic cells.

Dendritic cells as cancer therapeutics.

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Documenting hospice care.

After the wood chipper.

Assisted dying and the silencing of medicine's next generation.

相关实验视频

树突细胞生物学演变为临床应用.

相关概念视频

相关文章

Distinguishing human peripheral blood CD16<sup>+</sup> myeloid cells based on phenotypic characteristics.

CD300f epitopes are specific targets for acute myeloid leukemia with monocytic differentiation.

CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential.

Examination of CD302 as a potential therapeutic target for acute myeloid leukemia.

The cell surface phenotype of human dendritic cells.

Dendritic cells as cancer therapeutics.

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Documenting hospice care.

After the wood chipper.

Assisted dying and the silencing of medicine's next generation.